Cutting down on sleep impairs blood vessel functions

A new study found that reducing the duration of sleep for two consecutive nights leads to a less healthy vascular function and impaired breathing control.

The researchers worked with eight healthy adult volunteers aged 20-35 and for the first two nights of the study participants slept for eight hours a night but from there on, instead of restricting sleep completely, they gave them only four hours sleep for the next three consecutive nights.

After the first two nights of restricted sleep, the researchers found a significant reduction in vascular function compared with those following a normal night’s sleep. However, after the third night of sleep restriction vascular function returned to baseline, possibly because of an adaptive response to acute sleep loss.

The results may suggest a mechanism behind the relationship between sleep deprivation and cardiovascular disease. If acute sleep loss occurs repeatedly over a long period of time, then vascular health may be further compromised and finally mediate the development of cardiovascular disease.

SOLACI.ORG

More articles by this author

Women Present Lower Risk of Sport Related Sudden Death Compared to Men

According to this recent analysis published in Eur Heart J, women would have a far lower chances of dying suddenly for physical exertion during...

Saturated Fats: Dietary Angels or Demons?

In order to reduce cardiovascular events, dietary guidelines recommend restricting saturated fatty acids—without taking into account differences among them—to <10% of the daily caloric...

Low-Carb Diet and Coronary Artery Calcium Progression

People on low carb diets since a young age present increased risk of coronary artery calcium progression, particularly when carbs are replaced by animal...

Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...